【今日头条】 三部门印发《新一轮农村公路提升行动方案》目标到 2027 年全国完成新改建农村公路 30 万公里 交通运输部、财政部、自然资源部印发《新一轮农村公路提升行动方案》，到 2027 年，全国完成新改 建农村公路 30 万公里，便捷高效、普惠公平的农村公路网络基本建成；实施修复性养护工程 30 万公 里，技术状况优良路率保持在 70% 以上，实施安全生命防护工程 15 万公里，改造危旧桥梁 9000 座， 农村公路安全和服务保障能力进一步提升；建制村通公交率达到 55% 以上，力争具备条件的县级行政 区基本实现农村客货邮融合发展全覆盖，城乡交通运输服务水平进一步提升，为到 2035 年建成"规模结 构合理、设施品质优良、治理规范有效、运输服务优质"的农村公路交通运输体系，实现"人享其行、物 畅其流"的美好愿景提供有力支撑。涉及港股工程机械、建筑建材板块。 【大势展望】 隔夜美股悉数上涨 热门中概股多数上涨 隔夜美股截至收盘，道指涨81.38点，涨幅为0.19%，报44193.12点；纳指涨252.87点，涨幅为1.21%，报 21169.42点；标普500指数涨45.87点，涨幅为0.73%，报634 ...

格隆汇8月6日丨广南(集团)(01203.HK)发布公告，粤海里水食品（公司间接非全资附属公司）成功投得 位于中国广东省佛山市里水镇的该地块的用地使用权，代价为人民币5616万元，据此，于2025年8月6 日，佛山市公共资源交易中心与粤海里水食品就成功投标订立成交确认书。 集团透过其附属公司粤海里水食品，致力于在佛山市南海区里水镇发展一间现代化、高标准的屠宰企 业。该地块位於成熟工业区内的优越位置，毗邻主要高速公路及交通网络，具备便捷的联通优势。此战 略位置有助于牲畜及制成品的高效运输，降低物流成本，并确保能及时送达香港及大湾区其他主要市 场。该位置与住宅及商业区相互分隔，可最大限度减少对环境及社会的潜在影响，为产业的可持续发展 提供支持。 收购该地块的用地使用权将使集团进一步整合其在食品生产价值链中的各项业务，涵盖从牲畜屠宰、肉 类加工到冷藏及配送等环节。此项垂直整合预期将提升供应链效率、改善产品质量与安全水平，并增强 集团应对市场对高质量肉制品需求的能力。收购亦将成为集团扩大经营规模的平台，助力其在屠宰及食 品业务领域实现更大的协同效应。 该地块位于中国广东省佛山市南海区里水镇石塘「大秧地」（地块编号：Y ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 （於 香 港 註 冊 成 立 的 有 限 公 司） （股 份 代 號：01203） 關於收購位於佛山市里水鎮之用地使用權的 須予披露交易 收購用地使用權 收購用地使用權 茲提述本公司日期為2024年12月27日的公告，內容有關成立粵海里水食品。 董 事 會 欣 然 宣 佈，粵 海 里 水 食 品（本 公 司 之 間 接 非 全 資 附 屬 公 司）成 功 投 得 位 於 中 國 廣 東 省 佛 山 市 里 水 鎮 之 該 地 塊 的 用 地 使 用 權，代 價 為 人 民 幣56,160,000元（相 當 於 約61,658,000港 元），據 此，於2025年8月6日，佛 山 市 公 共 資 源 交 易 中 心 與 粵 海 里 水 食 品 就 成 功 投 標 訂 立 成 交 確 認 書。 《用 地 使 用 權 出 讓 合 同》將 由 ...

Financial Performance - For the first quarter of 2025, the company's unaudited consolidated revenue was HKD 2.879 billion, representing a 20% increase compared to HKD 2.399 billion in the same period last year[4]. - The profit attributable to equity holders of the company for the first quarter of 2025 was HKD 34.77 million, a significant increase of 260% from HKD 9.65 million in the previous year[4]. - The total assets as of March 31, 2025, were HKD 5.035 billion, reflecting a 2% increase from HKD 4.938 billion as of December 31, 2024[4]. Segment Performance - The food biotechnology segment generated revenue of HKD 2.355 billion, a 21% increase year-on-year, despite a 7% decline in segment profit to HKD 44.59 million[7]. - The tinplate business produced 76,000 tons of products, a 10% increase year-on-year, with sales of 75,000 tons, representing a 19% increase[8]. - The revenue from the tinplate business was HKD 520 million, a 15% increase compared to the previous year, with segment profit rising 314% to HKD 19.76 million[8]. Challenges and Considerations - The company expects to continue facing challenges due to price fluctuations in pork and demand variability in the tinplate business[12]. - The company emphasizes that quarterly performance may not be indicative of annual results due to market conditions and seasonal factors[12]. Asset Valuation - The company has not recorded any valuation gains or losses on investment properties, maintaining stable property values[10]. - The unaudited financial data for the first quarter of 2025 has been reviewed by the company's audit committee[11].

Financial Performance - The company's consolidated revenue for 2024 reached HKD 11.98 billion, a 15% increase from HKD 10.39 billion in 2023[6]. - Consolidated profit attributable to shareholders was HKD 140.75 million, up 114% from HKD 65.92 million in 2023[7]. - Basic earnings per share increased to HKD 0.1551, a 114% rise compared to HKD 0.0726 in 2023[6]. - Revenue from the food biological segment reached HKD 9.929 billion, a 22% increase year-on-year, with segment profit rising 133% to HKD 234 million[14]. - The group's revenue from the tinplate business was HKD 2.032 billion, a decrease of 10% compared to 2023, with segment profit dropping 55% to HKD 38.51 million[16]. - The property leasing business reported an occupancy rate of 84%, down 3 percentage points from 2023, with revenue decreasing by 10% to HKD 18.03 million[18]. - Net profit for the year increased to HKD 171,022 thousand, a significant rise of 84.3% compared to HKD 92,777 thousand in 2023[158]. - Total comprehensive income for the year was HKD 118,048 thousand, up from HKD 47,097 thousand in 2023, marking a growth of 150.5%[159]. Dividends and Shareholder Returns - The board proposed a final dividend of HKD 0.025 per share, representing a 25% increase from the previous year's HKD 0.020[7]. - The company reported a mid-term dividend of HKD 0.01 per share for 2024, consistent with 2023, and proposed a final dividend of HKD 0.025 per share, up from HKD 0.02 in 2023[43]. - The company aims to maintain a stable and sustainable dividend policy, with dividends proposed semi-annually, subject to the board's assessment of financial performance and future prospects[45]. - The company declared dividends of HKD 9,076,000 for the year, consistent with the previous year's dividend declaration[165]. Assets and Liabilities - Total assets as of December 31, 2024, were HKD 4.94 billion, a 3% increase from HKD 4.79 billion in 2023[6]. - Total assets as of December 31, 2024, amounted to HKD 4.938 billion, while total liabilities increased to HKD 2.081 billion[20]. - Non-current assets decreased to HKD 2,125,575 thousand in 2024 from HKD 2,219,337 thousand in 2023, a decline of 4.2%[161]. - Current assets increased to HKD 2,812,739 thousand in 2024, up from HKD 2,569,664 thousand in 2023, representing a growth of 9.5%[161]. - Total liabilities decreased to HKD 2,856,836 thousand in 2024 from HKD 2,795,645 thousand in 2023, a reduction of 2.1%[162]. - The company’s equity attributable to shareholders increased to HKD 2,592,751 thousand in 2024 from HKD 2,570,014 thousand in 2023, reflecting a growth of 0.9%[162]. Operational Developments - The company plans to invest in an integrated supply chain platform for livestock, including slaughtering, processing, cold chain distribution, and fresh marketing[8]. - The company aims to expand its retail network in Hong Kong and diversify its fruit and vegetable product offerings[8]. - The joint venture in live pig farming turned profitable in 2024, benefiting from improved market conditions and reduced costs[9]. - The company is focused on enhancing its tinplate product quality and expanding its customer base both domestically and internationally[9]. - The group achieved a slaughter volume of over 3 million pigs, securing a leading market share in Guangdong Province[14]. - The group aims to enhance operational efficiency through digital transformation and supply chain optimization in the food biological segment[11]. Investments and Capital Expenditure - Capital expenditure for 2024 was HKD 54.37 million, significantly lower than HKD 261 million in 2023[23]. - The group plans to invest approximately HKD 302 million in capital expenditures for 2025[23]. - The group entered a partnership to establish a slaughterhouse in Foshan with a registered capital of RMB 90 million, with the group holding a 65% stake[24]. Risk Management and Compliance - The group has strengthened its foreign exchange market research and monitoring to mitigate foreign exchange risk, particularly from USD to RMB fluctuations[28]. - The company has implemented internal controls and monitoring systems to manage accounts receivable risks associated with customer creditworthiness[50]. - The company is actively seeking to diversify suppliers for its food biological business to reduce reliance on major suppliers and mitigate risks from potential policy changes[54]. - The company has established a safety production system to mitigate risks associated with machinery operations in its slaughtering and food processing businesses[51]. - The company is committed to enhancing environmental protection measures to mitigate negative impacts from its operations on the environment[53]. Corporate Governance - The board of directors includes both executive and non-executive members, with specific terms for re-election outlined[70]. - The board consists of seven members, including three independent non-executive directors, ensuring a balanced structure for effective oversight[116]. - The company has adhered to the corporate governance code, with the exception of the separation of roles between the chairman and the CEO[103]. - The independent non-executive directors have confirmed their independence as per the listing rules[108]. - The company encourages directors to participate in professional development courses related to corporate governance and compliance, ensuring they remain informed about legal and regulatory updates[113]. Audit and Financial Reporting - The audit committee has reviewed the annual performance for the year ending December 31, 2024[99]. - KPMG has been proposed for reappointment as the independent auditor at the upcoming annual general meeting[100]. - The audit opinion confirmed that the consolidated financial statements fairly present the financial position of the group as of December 31, 2024, in accordance with Hong Kong Financial Reporting Standards[142]. - The auditor's fees for the year ending December 31, 2024, totaled HKD 4,037,000, with HKD 2,800,000 for audit services and HKD 1,237,000 for non-audit services[126]. - The audit committee held four meetings during the year, reviewing the group's 2023 full-year performance and 2024 interim and quarterly results[127]. Environmental and Social Responsibility - The company has committed to environmental sustainability, adhering to international and local regulations, and aims to reduce greenhouse gas emissions[65]. - The company made donations totaling HKD 99,000 during the year, slightly down from HKD 100,000 in 2023[68]. - The company is committed to providing quality products through responsible environmental management and appropriate technology[102].

Financial Performance - The company reported a total revenue of HKD 11,978.79 million for the year ended December 31, 2024, representing a 15% increase from HKD 10,385.81 million in 2023[3]. - Shareholders' profit attributable to the company was HKD 140.75 million, a significant increase of 114% compared to HKD 65.92 million in 2023[3]. - Basic earnings per share rose to HKD 15.51, up 114% from HKD 7.26 in the previous year[3]. - The net profit for 2024 is HKD 171.02 million, compared to HKD 92.78 million in 2023, showing an increase of about 84.3%[40]. - The group reported a profit of HKD 280,654,000 for 2024, an increase of 43.7% compared to HKD 195,245,000 in 2023[61]. - Total comprehensive income for the year amounted to HKD 118,048,000, up 150.5% from HKD 47,097,000 in the previous year[41]. - The food bio division's profit was HKD 234,035,000, significantly up from HKD 100,369,000 in 2023[59]. Dividends - The board proposed a final dividend of HKD 2.50 per share, an increase of 25% from HKD 2.00 per share in 2023, resulting in a total dividend of HKD 3.50 per share for the year, up 17%[5]. - The proposed final dividend per ordinary share increased to HKD 0.025 in 2024 from HKD 0.020 in 2023, reflecting a growth of 25.0%[74]. - The company declared an interim dividend of HKD 0.01 per share for 2024, consistent with 2023[94]. - The eligibility period for shareholders to receive the proposed final dividend will be from June 26 to June 27, 2025[95]. - Shareholders must submit all relevant documents by June 25, 2025, to qualify for the final dividend[95]. Business Operations and Strategy - The company is focusing on the food biotechnology sector, aiming to strengthen its supply chain from slaughtering to fresh product sales, and is investing in digital transformation to optimize business processes[6][12]. - A new project was established in collaboration with Foshan Nanhai Dream Water Town Investment Co., Ltd. to build and operate a modern slaughterhouse, integrating processing, cold chain distribution, and sales[7]. - The company plans to enhance its market presence in the food biotechnology sector by expanding its retail network and diversifying its product offerings[7]. - The company aims to drive technological innovation in the tinplate business to improve product quality and competitiveness, while also expanding its customer base both domestically and internationally[10]. - The group has established a joint venture for a slaughterhouse project in Foshan with a registered capital of RMB 90 million, where the group holds a 65% stake[29]. - The group plans to explore new business models and strengthen risk management to adapt to the complex market environment[17]. Market and Economic Outlook - The outlook for 2025 indicates that the company will face new opportunities and challenges due to structural reforms and innovation-driven strategies in the Chinese economy[11]. - The pig farming sector in mainland China is showing signs of improvement, with rising prices and reduced costs due to better feed prices and farming efficiency, leading to profitability for one of the company's joint ventures[8]. - Revenue from external customers in Hong Kong increased to HKD 1,114,387,000 in 2024 from HKD 809,087,000 in 2023, representing a growth of 37.7%[64]. - Revenue from external customers in mainland China rose to HKD 10,365,267,000 in 2024 compared to HKD 9,064,873,000 in 2023, an increase of 14.3%[64]. Financial Position - Total assets as of December 31, 2024, amounted to HKD 4.938 billion, an increase of HKD 149 million from the previous year[24]. - Cash and cash equivalents decreased by 8% to HKD 955 million, with 79.1% held in RMB[25]. - The group has available bank credit facilities of HKD 2.746 billion, with HKD 813 million already utilized[26]. - Total liabilities increased to HKD 2,081,478,000, compared to HKD 1,993,356,000 in 2023, marking an increase of 4.4%[43]. - The company reported a net asset value of HKD 2,856,836,000, up from HKD 2,795,645,000, representing a growth of 2.2%[43]. - The group’s liabilities rose to HKD 2,081,478,000 in 2024, compared to HKD 1,993,356,000 in 2023[61]. Operational Efficiency - The group aims to enhance asset operation efficiency and optimize capital structure to ensure stable growth in operating performance[15]. - The group achieved a slaughter volume of over 3 million live pigs, securing a leading market share in Guangdong Province[17]. - The rental property business recorded an occupancy rate of 84%, down 3 percentage points from 2023, with revenue of HKD 18.03 million, a decrease of 10%[22]. - The group’s capital expenditure for 2024 is HKD 54.37 million, a decrease from HKD 261 million in 2023[27]. Other Financial Metrics - The gross profit for 2024 is HKD 509.01 million, down from HKD 568.99 million in 2023, indicating a decrease of about 10.4%[40]. - The operating profit for 2024 is HKD 236.15 million, a decline from HKD 278.22 million in 2023, reflecting a decrease of approximately 15.1%[40]. - Interest income from financial assets measured at amortized cost decreased to HKD 7,632,000 in 2024 from HKD 13,639,000 in 2023, a decline of 44.0%[66]. - Total employee costs increased to HKD 338,988,000 in 2024 from HKD 309,670,000 in 2023, representing a growth of 9.5%[69]. - The effective tax rate for Hong Kong profits tax remained at 16.5% for both 2024 and 2023[71].

Financial Performance - For the nine months ended September 30, 2024, the company's unaudited consolidated revenue was HKD 8,584.97 million, an increase of 10.3% compared to HKD 7,786.51 million for the same period last year[3]. - The company's unaudited consolidated operating profit for the same period was HKD 189.77 million, a decrease of 11.2% from HKD 213.76 million year-on-year[3]. - The unaudited consolidated profit attributable to shareholders was HKD 115.82 million, representing an 18.0% increase from HKD 98.12 million as of December 31, 2023[3]. Business Segments - The food biological business generated revenue of HKD 7,068.00 million, a 16.4% increase year-on-year, with a segment profit of HKD 156.70 million, up 2.3%[6]. - The live pig slaughter volume exceeded 2.29 million heads, with a market share in Guangdong province ranking among the top[6]. - The tinplate business recorded a revenue of HKD 1,504.00 million, a decrease of 11.6%, with a segment profit of HKD 32.83 million, down 53.7%[7]. Asset and Equity - Total assets as of September 30, 2024, were HKD 4,832.80 million, a 0.9% increase from HKD 4,789.00 million[3]. - Shareholders' equity increased by 2.2% to HKD 2,627.54 million from HKD 2,570.01 million[3]. Market Conditions - The company expects continued volatility in pig prices and fluctuations in customer demand and raw material prices affecting the food biological and tinplate businesses[9]. - The value of the investment properties held by the group decreased, resulting in a valuation loss of HKD 6.75 million for the period[8].

Financial Performance - The company's unaudited consolidated revenue for the first half of 2024 was HKD 5.417 billion, an increase of 8.6% compared to HKD 4.989 billion in the same period last year[6]. - The unaudited consolidated operating profit was HKD 130.533 million, a decrease of 6.3% from HKD 139.252 million year-on-year[6]. - The unaudited consolidated profit attributable to shareholders was HKD 57.727 million, down 2.4% from HKD 59.132 million in the previous year[6]. - The basic earnings per share for the first half of 2024 was 6.4 HK cents, a decrease of 1.5% compared to 6.5 HK cents in the same period last year[6]. - The company reported a total comprehensive income of HKD 53,233 thousand, a significant recovery from a loss of HKD 16,004 thousand in the previous year[27]. - The company reported a profit of HKD 57,727,000 for the six months ended June 30, 2024, compared to the previous period[30]. - The company reported a comprehensive profit before tax of HKD 94,770,000, compared to HKD 98,378,000 in 2023[41]. - The company reported a pre-tax profit of HKD 15,368,000 for the six months ended June 30, 2024, compared to HKD 9,984,000 for the same period in 2023, reflecting an increase of approximately 53.8%[44]. Segment Performance - The revenue from the food biological segment was HKD 4.429 billion, accounting for 81.8% of the group's total revenue, representing a 15.6% increase year-on-year[7]. - The profit from the food biological segment, excluding losses from joint ventures, was HKD 96.91 million, an increase of 7.8% year-on-year[7]. - Revenue from the tinplate business was HKD 979 million, a decrease of HKD 169 million or 14.7% year-on-year, with segment profit dropping 71.0% to HKD 14.98 million[8]. - Revenue from the food bio segment was HKD 4,357,394,000, up 16.1% from HKD 3,753,369,000 in 2023[37]. - The property leasing segment generated rental income of HKD 8,649,000, a decrease of 13.5% from HKD 9,997,000 in 2023[37]. - The total profit from the reporting segments was HKD 97,038,000, down 16.9% from HKD 116,662,000 in 2023[41]. Cash Flow and Liquidity - Cash and cash equivalents were HKD 736 million, a decrease of 28.9%, with 80.7% in RMB and 3.1% in USD[13]. - The company reported a net loss from operating activities of HKD 134,822,000 for the six months ended June 30, 2024, compared to a net cash generated of HKD 59,892,000 in the same period last year[32]. - Cash and cash equivalents decreased by HKD 294,848,000 during the six months ended June 30, 2024, compared to a decrease of HKD 250,398,000 in the prior year[32]. - The company incurred a cash outflow of HKD 688,820,000 from bank loan repayments during the six months ended June 30, 2024, compared to HKD 222,743,000 in the same period last year[32]. - The company reported a cash inflow of HKD 269,432,000 from financing activities for the six months ended June 30, 2024, compared to HKD 27,194,000 in the same period last year[32]. Assets and Liabilities - Total assets as of June 30, 2024, were HKD 4.703 billion, while total liabilities decreased to HKD 1.913 billion[12]. - The company's total equity as of June 30, 2024, was HKD 2,739,468,000, a decrease from HKD 2,783,913,000 as of January 1, 2023[31]. - Total liabilities decreased to HKD 580,452,000 from HKD 628,547,000, marking a reduction of approximately 7.65%[29]. - The company’s equity attributable to shareholders decreased to HKD 2,552,105,000 from HKD 2,570,014,000, a decline of approximately 0.70%[29]. - The total liabilities of the reporting segments were HKD 1,731,043,000, a decrease from HKD 1,814,168,000 in 2023[40]. Dividends - The company declared an interim dividend of 1.0 HK cent per share, unchanged from the previous year[7]. - The company declared dividends amounting to HKD 18,152,000 during the period[30]. - The group declared an interim dividend of HKD 9,076,000 for the period ending June 30, 2024, consistent with the previous year[61]. - The company announced an interim dividend of HKD 0.01 per share for 2024, consistent with the previous year's dividend[91]. Strategic Focus - The company aims to leverage opportunities from industrial upgrades and domestic demand expansion while managing risks from external market fluctuations[21]. - The food bio-business will focus on innovation and quality, aiming to enhance its brand image as a premium food supplier in the Greater Bay Area[21]. - The tinplate business is committed to optimizing product quality and technology to meet high standards across various industries[21]. - The company emphasizes prudent risk management and flexible operational strategies to ensure steady growth amid global economic uncertainties[21]. - The company plans to strengthen strategic partnerships and market research to capture new market opportunities and enhance its competitive position[21]. Employment and Workforce - The number of full-time employees decreased to 1,462, down 58 from the end of 2023[20]. - The company’s short-term employee benefits for key management personnel were HKD 1,606,000, slightly down from HKD 1,623,000 in 2023[76]. Governance and Compliance - The company’s board and directors confirmed compliance with the corporate governance code during the six months ending June 30, 2024[84]. - The company’s audit committee reviewed the unaudited interim financial report for the six months ending June 30, 2024[87]. - The company has no outstanding principal on its loan financing agreements as of June 30, 2024, including a one-year loan of HKD 400 million[88].

Financial Performance - The group's unaudited consolidated revenue for the first half of 2024 was HKD 5.417 billion, an increase of 8.6% compared to HKD 4.989 billion in the same period last year[3]. - The unaudited consolidated operating profit was HKD 130.53 million, a decrease of 6.3% from HKD 139.25 million year-on-year[3]. - The unaudited consolidated profit attributable to shareholders was HKD 57.73 million, down 2.4% from HKD 59.13 million in the previous year[3]. - Gross profit for the same period was HKD 240,971,000, down 16.7% from HKD 289,624,000 in 2023[19]. - The operating profit decreased to HKD 130,533,000, a decline of 6.2% from HKD 139,252,000 in the previous year[19]. - The net profit attributable to the company's shareholders was HKD 57,727,000, a decrease of 2.4% compared to HKD 59,132,000 in 2023[19]. - Segment profit, including share of losses from joint ventures, was 97,038 thousand for the first half of 2024, down from 116,662 thousand in 2023, indicating a decline of about 16.9%[27]. Revenue Breakdown - The revenue from the food biological segment was HKD 4.429 billion, accounting for 81.8% of the group's total revenue, with a year-on-year increase of 15.6%[5]. - Sales of food biological products amounted to HKD 4,357,394,000, up 16.1% from HKD 3,753,369,000 in the previous year[25]. - The tinplate business generated revenue of HKD 979 million, a decrease of 14.7% compared to the previous year, with a segment profit decline of 71.0% to HKD 14.98 million[6]. - The revenue from tinplate products decreased to HKD 979,256,000, down 14.8% from HKD 1,147,796,000 in the prior year[25]. - The property leasing segment reported an occupancy rate of 82.6%, down 8.0% year-on-year, with revenue of HKD 8.65 million, a decrease of 13.5%[7]. - The rental income from property leasing was HKD 8,649,000, down from HKD 9,997,000 in the previous year[25]. Assets and Liabilities - As of June 30, 2024, the group's total assets were HKD 4.703 billion, while total liabilities were HKD 1.913 billion, reflecting a decrease in both compared to the end of 2023[9]. - The group's cash and cash equivalents amounted to HKD 736 million, a decrease of 28.9% from the end of 2023, with 80.7% in RMB[10]. - Total assets as of June 30, 2024, were 4,702,840 thousand, slightly decreased from 4,789,001 thousand as of December 31, 2023, reflecting a reduction of approximately 1.8%[28]. - Total liabilities decreased to 1,913,144 thousand as of June 30, 2024, from 1,993,356 thousand at the end of 2023, a decline of about 4.0%[28]. - The company's total assets less current liabilities stood at HKD 3,370,148,000, a decrease from HKD 3,424,192,000 at the end of 2023[21]. - The net asset value was HKD 2,789,696,000, a slight decrease from HKD 2,795,645,000 at the end of 2023[21]. Cash Flow and Expenditures - The capital expenditure for the first half of 2024 was HKD 23.42 million, with an estimated total capital expenditure for the year projected at HKD 51.90 million[11]. - The cost of acquiring and relocating property, plant, and equipment for the six months ended June 30, 2024, was HKD 23,420,000, a significant decrease from HKD 259,432,000 in the same period of 2023[38]. - The net cash and cash equivalents as of June 30, 2024, were HKD 736,175,000, a decrease of 29.0% from HKD 1,035,928,000 at the end of 2023[21]. - The available bank financing as of June 30, 2024, was HKD 3,303,849,000, slightly down from HKD 3,308,374,000 as of December 31, 2023[44]. Employee and Operational Metrics - The group employed 1,462 full-time employees as of June 30, 2024, a decrease of 3.8% from 1,520 employees at the end of 2023[16]. - The company is focusing on innovation and quality in its food biotechnology business, aiming for sustainable development and market expansion in the Guangdong-Hong Kong-Macao Greater Bay Area[17]. - The group is enhancing its risk management and optimizing core business strategies to ensure stable growth amid global economic uncertainties[17]. Dividends and Shareholder Information - The company maintained a mid-term dividend of HKD 9,076,000, unchanged from the previous year[19]. - The interim dividend declared for the period was 9,076 thousand, consistent with the same amount declared in the previous year[35]. - The board declared an interim dividend of HKD 0.01 per share for 2024, consistent with the interim dividend of HKD 0.01 per share in 2023[47]. Compliance and Governance - The mid-term performance announcement is published on the Hong Kong Stock Exchange website and the company's website[51]. - The board of directors includes three executive directors and three independent non-executive directors[51]. - The announcement date is August 30, 2024, indicating a timely update for shareholders[51]. - The company is committed to ensuring the accuracy of the information provided in the report[51]. - The chairman of the board is Chen Ben Guang, highlighting leadership continuity[51]. - The board composition suggests a balanced governance structure with both executive and independent members[51].

Financial Performance - For the first quarter of 2024, the company's unaudited consolidated revenue was HKD 2,398.67 million, an increase of 3.0% compared to HKD 2,329.72 million in the same period last year[3]. - The company's unaudited consolidated operating profit for the first quarter of 2024 was HKD 51.25 million, a decrease of 5.5% from HKD 54.23 million year-on-year[3]. - The unaudited consolidated profit attributable to shareholders for the first quarter of 2024 was HKD 9.65 million, down 41.1% from HKD 16.37 million in the same period last year[3]. Asset Management - Total assets as of March 31, 2024, were HKD 4,649.09 million, a decrease of 2.9% from HKD 4,789.00 million at the end of December 2023[3]. Business Segments - The food biological business generated revenue of HKD 1,942.00 million in the first quarter of 2024, an increase of 8.7% year-on-year, with a market share of approximately 49% in the live pig market in Hong Kong[7]. - The live pig slaughter volume exceeded 760,000 heads in the first quarter of 2024, representing a year-on-year increase of 16.4%[7]. - The tinplate business produced 69,000 tons of products in the first quarter of 2024, an increase of 9.5% year-on-year, but sales decreased by 4.5% to 63,000 tons[9]. - Revenue from the tinplate business was HKD 453.00 million, a decrease of 16.0% compared to the same period last year, with segment profit down 75.7%[9]. Valuation and Challenges - The company recorded an investment property valuation loss of HKD 0.84 million in the current period, whereas there was no valuation loss in the same period last year[10]. - The company anticipates ongoing challenges in the food biological business due to falling pig prices and fluctuations in demand and raw material prices in the tinplate business[11].